ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Avid Bioservices, Inc.
12.49
0.0000
成交量:
- -
成交額:
3,831.71萬
市值:
7.99億
市盈率:
-5.22
高:
12.49
開:
12.49
低:
12.49
收:
12.49
52周最高:
12.51
52周最低:
5.90
股本:
6,396.33萬
流通股本:
5,062.31萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-2.3946
每股收益(LYR):
-2.2271
淨資產收益率:
-133.29%
總資產收益率:
-3.27%
市淨率:
17.83
市盈率(LYR):
-5.61
資料載入中...
總覽
公司
新聞資訊
公告
BioHarvest發布2026年業績指引 D2C與CDMO雙輪驅動
环球市场播报
·
05/15
今日普洛藥業(000739)漲停分析:CDMO放量、綠色工藝落地、新品獲批驅動
中金财经
·
05/11
CDMO龍頭三星生物罷工:中國CDMO企業迎訂單轉移窗口期?
21世纪经济报道
·
05/08
康龍化成:小分子CDMO一季度訂單加速增長來自兩方面因素
证券日报
·
04/30
誠達藥業2025年營收4.06億元增21.99%,CDMO成第一大收入來源,扣非淨利仍虧2669.29萬元
蓝鲸财经
·
04/27
褪去新冠商業化紅利反而更強了!藥明康德(02359)小分子CDMO單季度收入飆至69.3億元
智通财经
·
04/27
港股異動 | 凱萊英(06821)尾盤升逾5% 20億元化學大分子CDMO項目落地天津 TIDES持續擴能擴產
智通财经
·
04/27
港股異動 | 凱萊英(06821)午後漲近6% 20億元化學大分子創新藥CDMO項目落地天津經開區
智通财经
·
04/24
【機構調研精選】這家CRO公司年初至今新簽訂單保持增長勢頭,小分子CDMO服務毛利率有望提高!
人民财讯
·
04/02
康龍化成:製劑商業化車間投產獲國際大藥企訂單 小分子CDMO毛利率有望提升
每日经济新闻
·
04/01
東曜藥業-B(01875)發布年度業績,收益7.48億元 戰略轉型CDMO成果顯著
智通财经
·
03/18
美國OTC市場Scorpius Holdings, Inc.盤中異動 早盤股價大漲25.00%報0.015美元
市场透视
·
03/12
新華製藥:公司構建創新藥+特色原料藥+高端製劑+CDMO立體佈局
证券日报
·
03/09
美國OTC市場Scorpius Holdings, Inc.盤中異動 下午盤快速上漲72.41%報0.010美元
市场透视
·
02/24
大行評級丨高盛:內地醫療健康板塊的強勁趨勢將延續,對CDMO企業看好轉趨建設性
中金财经
·
02/09
普洛藥業:CDMO項目數持續保持較快增長
中金财经
·
02/05
外資CDMO紛紛易手,它們在華消失殆盡了 | 海斌訪談
第一财经
·
01/30
千億藥明系,連環資本局
蓝鲸财经
·
01/29
515億温州富豪,28億吞併蘇州藥企
21世纪经济报道
·
01/16
業績盈喜, 控股收購東曜藥業,藥明合聯(02268)進一步穩固ADC CDMO市場地位
智通财经
·
01/14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CDMO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDMO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":12.49,"timestamp":1738702800000,"preClose":12.49,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":50623090,"shares":63963302,"eps":-2.394638,"marketStatus":"停牌","change":0,"latestTime":"02-04 16:00:00 EST","open":12.49,"high":12.49,"low":12.49,"amount":38317107.960278,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.394638,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":12.49,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","floatShares":50623090,"roa":"-3.27%","roe":"-133.29%","lyrEps":-2.227139,"shares":63963302,"dividePrice":0,"high":12.49,"amplitude":0,"preClose":12.49,"low":12.49,"week52Low":5.9,"pbRate":"17.83","psRate":"5.31","week52High":12.51,"institutionHeld":0.9807,"latestPrice":12.49,"eps":-2.394638,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.394638,"open":12.49,"prevYearClose":12.35,"prevWeekClose":12.48,"prevMonthClose":12.48,"prevQuarterClose":12.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDMO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"CDMO","reason":null,"defaultRemindTime":1738852200000,"announcedDate":"2025-02-04","type":"delisting","dateTimestamp":1738818000000},{"market":"US","date":"2024-12-10","symbol":"CDMO","fiscalQuarterEnding":"2024/10","expectedEps":-0.13,"name":null,"time":"盤後","type":"earning","dateTimestamp":1733806800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-09-09","symbol":"CDMO","fiscalQuarterEnding":"2024/07","expectedEps":-0.08,"name":null,"time":"盤後","type":"earning","dateTimestamp":1725854400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-07-02","symbol":"CDMO","fiscalQuarterEnding":"2024/04","expectedEps":0.03,"name":null,"time":"盤後","type":"earning","dateTimestamp":1719892800000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-04-24","symbol":"CDMO","fiscalQuarterEnding":"2024/01","expectedEps":-0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDMO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDMO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733374800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CDMO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CDMO","date":"2025-02-04","current":-5.21582,"percent":0.349064,"low":-236.80087,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"high":9284.394324,"avg":397.880667,"sd":1431.818994,"marketCap":798262008},"quantilePoints":[{"date":"2021-05-28","current":290.68771,"twenty":-77.30512,"median":-6.716829,"eighty":-1.871961,"marketCap":1294432373},{"date":"2021-06-04","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.85901,"marketCap":1407573549},{"date":"2021-06-11","current":315.68576,"twenty":-77.30512,"median":-6.716829,"eighty":-1.848648,"marketCap":1405748691},{"date":"2021-06-18","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.841619,"marketCap":1407573549},{"date":"2021-06-25","current":342.869433,"twenty":-77.30512,"median":-6.716829,"eighty":-1.832157,"marketCap":1526797583},{"date":"2021-07-02","current":142.499473,"twenty":-77.30512,"median":-6.716829,"eighty":-1.830139,"marketCap":1597704096},{"date":"2021-07-09","current":141.845556,"twenty":-77.30512,"median":-6.716829,"eighty":-1.821934,"marketCap":1590372376},{"date":"2021-07-16","current":136.83219,"twenty":-77.30512,"median":-6.716829,"eighty":-1.81215,"marketCap":1534162518},{"date":"2021-07-23","current":141.355118,"twenty":-77.30512,"median":-6.716829,"eighty":-1.799525,"marketCap":1584873585},{"date":"2021-07-30","current":139.774818,"twenty":-77.30512,"median":-6.716829,"eighty":-1.785372,"marketCap":1567155261},{"date":"2021-08-06","current":141.73657,"twenty":-77.30512,"median":-6.716829,"eighty":-1.764864,"marketCap":1589150422},{"date":"2021-08-13","current":136.723204,"twenty":-77.30512,"median":-6.716829,"eighty":-1.688839,"marketCap":1532940565},{"date":"2021-08-20","current":135.142904,"twenty":-77.30512,"median":-6.716829,"eighty":-1.617566,"marketCap":1515222240},{"date":"2021-08-27","current":132.180722,"twenty":-77.30512,"median":-6.716829,"eighty":-1.602452,"marketCap":1482010253},{"date":"2021-09-03","current":126.490823,"twenty":-77.30512,"median":-6.716829,"eighty":-1.594862,"marketCap":1418215110},{"date":"2021-09-10","current":101.036419,"twenty":-77.30512,"median":-6.716829,"eighty":-1.573195,"marketCap":1291851653},{"date":"2021-09-17","current":100.652615,"twenty":-77.30512,"median":-6.716829,"eighty":-1.534217,"marketCap":1286944334},{"date":"2021-09-24","current":105.881945,"twenty":-77.30512,"median":-6.716829,"eighty":-1.523573,"marketCap":1353806551},{"date":"2021-10-01","current":101.180345,"twenty":-77.30512,"median":-6.716829,"eighty":-1.517157,"marketCap":1293691897},{"date":"2021-10-08","current":108.088819,"twenty":-77.30512,"median":-6.716829,"eighty":-1.495908,"marketCap":1382023634},{"date":"2021-10-15","current":123.728834,"twenty":-77.30512,"median":-6.716829,"eighty":-1.484858,"marketCap":1581996872},{"date":"2021-10-22","current":124.73632,"twenty":-77.30512,"median":-6.716829,"eighty":-1.475257,"marketCap":1594878584},{"date":"2021-10-29","current":147.188857,"twenty":-77.30512,"median":-6.716829,"eighty":-1.460883,"marketCap":1881956729},{"date":"2021-11-05","current":163.980285,"twenty":-77.30512,"median":-6.716829,"eighty":-1.456578,"marketCap":2096651923},{"date":"2021-11-12","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.445734,"marketCap":2067208010},{"date":"2021-11-19","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.434782,"marketCap":2067208010},{"date":"2021-11-26","current":150.930947,"twenty":-77.30512,"median":-6.716829,"eighty":-1.432053,"marketCap":1929803086},{"date":"2021-12-03","current":138.697192,"twenty":-77.30512,"median":-6.716829,"eighty":92.966939,"marketCap":1773382302},{"date":"2021-12-10","current":116.804545,"twenty":-77.30512,"median":-6.716829,"eighty":99.366871,"marketCap":1638066942},{"date":"2021-12-17","current":114.169856,"twenty":-77.30512,"median":-6.716829,"eighty":101.093989,"marketCap":1601118064},{"date":"2021-12-23","current":129.714521,"twenty":-77.30512,"median":-6.716829,"eighty":102.54285,"marketCap":1819116446},{"date":"2021-12-31","current":128.133708,"twenty":-77.30512,"median":-6.716829,"eighty":106.764695,"marketCap":1796947119},{"date":"2022-01-07","current":97.527404,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1367724315},{"date":"2022-01-14","current":92.08238,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1291363300},{"date":"2022-01-21","current":79.918899,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1120782644},{"date":"2022-01-28","current":76.537715,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1073364917},{"date":"2022-02-04","current":85.056543,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192832957},{"date":"2022-02-11","current":93.180167,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1306758666},{"date":"2022-02-18","current":85.012631,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192217143},{"date":"2022-02-25","current":88.876842,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1246408831},{"date":"2022-03-04","current":81.148421,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1138025454},{"date":"2022-03-11","current":81.564879,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1147210023},{"date":"2022-03-18","current":96.139443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1352201265},{"date":"2022-03-25","current":94.690766,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1331825629},{"date":"2022-04-01","current":94.602968,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1330590742},{"date":"2022-04-08","current":83.057455,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1168203102},{"date":"2022-04-14","current":80.379598,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1130539048},{"date":"2022-04-22","current":75.418979,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1060767933},{"date":"2022-04-29","current":59.088443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":831078951},{"date":"2022-05-06","current":55.444802,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":779831140},{"date":"2022-05-13","current":54.96191,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":773039262},{"date":"2022-05-20","current":55.5765,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":781683471},{"date":"2022-05-27","current":60.449321,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":850219699},{"date":"2022-06-03","current":58.868947,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":827991733},{"date":"2022-06-10","current":55.620399,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":782300914},{"date":"2022-06-17","current":58.561652,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":823669629},{"date":"2022-06-24","current":68.52679,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":963829303},{"date":"2022-07-01","current":7.424698,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":947926104},{"date":"2022-07-08","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-15","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-22","current":8.48537,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1083344119},{"date":"2022-07-29","current":9.516981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1215052051},{"date":"2022-08-05","current":9.376527,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1197119985},{"date":"2022-08-12","current":9.536354,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1217525439},{"date":"2022-08-19","current":8.950321,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1142705440},{"date":"2022-08-26","current":8.930948,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1140232052},{"date":"2022-09-02","current":7.824981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":999030985},{"date":"2022-09-09","current":9.269592,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1139529431},{"date":"2022-09-16","current":8.637459,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1061820114},{"date":"2022-09-23","current":9.077423,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1115905799},{"date":"2022-09-30","current":9.669099,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1188641720},{"date":"2022-10-07","current":9.107766,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119635846},{"date":"2022-10-14","current":8.925711,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1097255563},{"date":"2022-10-21","current":7.868786,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":967325584},{"date":"2022-10-28","current":8.971225,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1102850633},{"date":"2022-11-04","current":6.928173,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851694119},{"date":"2022-11-11","current":7.767645,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":954892093},{"date":"2022-11-18","current":7.236653,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":889616266},{"date":"2022-11-25","current":7.438936,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":914483248},{"date":"2022-12-02","current":8.298636,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1020167920},{"date":"2022-12-09","current":6.812962,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":805660063},{"date":"2022-12-16","current":7.287183,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":861738490},{"date":"2022-12-23","current":7.202877,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851768992},{"date":"2022-12-30","current":7.255568,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":857999928},{"date":"2023-01-06","current":7.740326,"twenty":-77.30512,"median":-6.679923,"eighty":109.283255,"marketCap":915324542},{"date":"2023-01-13","current":8.593922,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1016265710},{"date":"2023-01-20","current":8.66769,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1024989021},{"date":"2023-01-27","current":8.636075,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1021250459},{"date":"2023-02-03","current":8.530693,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1008788586},{"date":"2023-02-10","current":8.699305,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1028727583},{"date":"2023-02-17","current":8.720381,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1031219957},{"date":"2023-02-24","current":8.620268,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1019381178},{"date":"2023-03-03","current":9.015451,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1066113200},{"date":"2023-03-10","current":7.350412,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":869215613},{"date":"2023-03-17","current":9.559254,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1113337596},{"date":"2023-03-24","current":9.382032,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1092697068},{"date":"2023-03-31","current":10.074809,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1173382770},{"date":"2023-04-06","current":10.203698,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1188394064},{"date":"2023-04-14","current":11.240179,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1309109882},{"date":"2023-04-21","current":10.289624,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1198401592},{"date":"2023-04-28","current":9.50555,"twenty":-77.30512,"median":-6.513848,"eighty":109.283255,"marketCap":1107082891},{"date":"2023-05-05","current":9.919068,"twenty":-77.30512,"median":-6.458489,"eighty":109.283255,"marketCap":1155244124},{"date":"2023-05-10","current":9.731105,"twenty":-77.30512,"median":-6.403131,"eighty":109.283255,"marketCap":1133352654},{"date":"2023-05-19","current":7.835366,"twenty":-77.358489,"median":-6.20015,"eighty":109.446474,"marketCap":912561547},{"date":"2023-05-26","current":8.168329,"twenty":-77.358489,"median":-6.107885,"eighty":109.446474,"marketCap":951340721},{"date":"2023-06-02","current":8.367032,"twenty":-77.358489,"median":-6.034074,"eighty":109.446474,"marketCap":974483132},{"date":"2023-06-09","current":9.194069,"twenty":-77.358489,"median":6.812962,"eighty":109.446474,"marketCap":1070805598},{"date":"2023-06-16","current":9.118884,"twenty":-77.385174,"median":6.991758,"eighty":109.528084,"marketCap":1062049010},{"date":"2023-06-23","current":1539.104598,"twenty":-77.386973,"median":7.174145,"eighty":110.625618,"marketCap":861898575},{"date":"2023-06-30","current":1496.538387,"twenty":-77.387872,"median":7.239761,"eighty":113.886744,"marketCap":838061497},{"date":"2023-07-07","current":1540.224762,"twenty":-77.387872,"median":7.287183,"eighty":118.166944,"marketCap":862525867},{"date":"2023-07-14","current":1497.65855,"twenty":-77.387872,"median":7.366219,"eighty":123.628937,"marketCap":838688788},{"date":"2023-07-21","current":1453.972175,"twenty":-77.387872,"median":7.424698,"eighty":125.174074,"marketCap":814224418},{"date":"2023-07-28","current":1438.289888,"twenty":-77.387872,"median":7.44905,"eighty":127.470924,"marketCap":805442337},{"date":"2023-08-04","current":1365.479263,"twenty":-77.387872,"median":7.624406,"eighty":129.89895,"marketCap":764668387},{"date":"2023-08-11","current":1437.169723,"twenty":-77.387872,"median":7.767645,"eighty":131.557258,"marketCap":804815045},{"date":"2023-08-18","current":1394.603513,"twenty":-77.387872,"median":7.840439,"eighty":132.799398,"marketCap":780977967},{"date":"2023-08-25","current":1319.552561,"twenty":-77.387872,"median":7.919356,"eighty":135.055715,"marketCap":738949434},{"date":"2023-09-01","current":1329.87968,"twenty":-77.387872,"median":8.066292,"eighty":136.461637,"marketCap":744732621},{"date":"2023-09-08","current":-236.80087,"twenty":-77.627134,"median":8.093067,"eighty":136.864886,"marketCap":733372293},{"date":"2023-09-15","current":-215.810775,"twenty":-79.724891,"median":8.093067,"eighty":136.864886,"marketCap":668365971},{"date":"2023-09-22","current":-193.597957,"twenty":-81.00567,"median":8.093067,"eighty":136.864886,"marketCap":599572873},{"date":"2023-09-29","current":-198.081278,"twenty":-81.501661,"median":8.093067,"eighty":136.864886,"marketCap":613457718},{"date":"2023-10-06","current":-191.356296,"twenty":-82.284183,"median":8.093067,"eighty":136.864886,"marketCap":592630450},{"date":"2023-10-13","current":-167.309392,"twenty":-83.104206,"median":8.093067,"eighty":136.864886,"marketCap":518157188},{"date":"2023-10-20","current":-142.039764,"twenty":-83.374176,"median":8.093067,"eighty":136.864886,"marketCap":439897149},{"date":"2023-10-27","current":-132.257973,"twenty":-83.539844,"median":8.114625,"eighty":137.082858,"marketCap":409602941},{"date":"2023-11-03","current":-125.125416,"twenty":-83.933555,"median":8.114625,"eighty":137.082858,"marketCap":387513414},{"date":"2023-11-10","current":-107.599706,"twenty":-84.748881,"median":8.114625,"eighty":137.082858,"marketCap":333236291},{"date":"2023-11-17","current":-105.561833,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":326924998},{"date":"2023-11-24","current":-111.87924,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":346490007},{"date":"2023-12-01","current":-103.727747,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":321244834},{"date":"2023-12-08","current":-29.21466,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":334507860},{"date":"2023-12-15","current":-32.03385,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":366787580},{"date":"2023-12-22","current":-35.402927,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":405363515},{"date":"2023-12-29","current":-37.501697,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":429394426},{"date":"2024-01-05","current":-33.911696,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":388288921},{"date":"2024-01-12","current":-37.336004,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":427497248},{"date":"2024-01-19","current":-33.746004,"twenty":-87.127444,"median":8.138341,"eighty":137.475209,"marketCap":386391744},{"date":"2024-01-26","current":-38.219697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":437615526},{"date":"2024-02-02","current":-36.397081,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":416746578},{"date":"2024-02-09","current":-36.562773,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":418643755},{"date":"2024-02-16","current":-42.527697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":486942132},{"date":"2024-02-23","current":-44.12939,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":505281511},{"date":"2024-03-01","current":-42.417236,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":485677347},{"date":"2024-03-08","current":-33.690773,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":385759351},{"date":"2024-03-15","current":-33.635542,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":385126959},{"date":"2024-03-22","current":-37.943543,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":434453565},{"date":"2024-03-28","current":-38.551081,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":441409881},{"date":"2024-04-05","current":-35.016312,"twenty":-84.693001,"median":8.125366,"eighty":137.279033,"marketCap":400936768},{"date":"2024-04-12","current":-38.109235,"twenty":-83.840428,"median":8.125366,"eighty":137.279033,"marketCap":436350742},{"date":"2024-04-19","current":-36.010466,"twenty":-83.520355,"median":8.125366,"eighty":137.279033,"marketCap":412319831},{"date":"2024-04-26","current":-26.277899,"twenty":-83.301704,"median":8.114625,"eighty":137.082858,"marketCap":464672092},{"date":"2024-05-03","current":-29.436991,"twenty":-82.558967,"median":8.114625,"eighty":137.082858,"marketCap":520534310},{"date":"2024-05-10","current":-29.221598,"twenty":-82.027926,"median":8.114625,"eighty":137.082858,"marketCap":516725523},{"date":"2024-05-17","current":-33.026868,"twenty":-81.364604,"median":8.114625,"eighty":137.082858,"marketCap":584014104},{"date":"2024-05-24","current":-31.698613,"twenty":-80.745541,"median":8.114625,"eighty":137.082858,"marketCap":560526581},{"date":"2024-05-31","current":-28.539522,"twenty":-79.544946,"median":8.114625,"eighty":137.082858,"marketCap":504664362},{"date":"2024-06-07","current":-28.826712,"twenty":-77.386073,"median":8.114625,"eighty":137.082858,"marketCap":509742745},{"date":"2024-06-14","current":-24.770151,"twenty":-75.623994,"median":8.125366,"eighty":137.279033,"marketCap":438010578},{"date":"2024-06-21","current":-24.447062,"twenty":-74.423568,"median":8.138341,"eighty":137.475209,"marketCap":432297397},{"date":"2024-06-28","current":-25.165037,"twenty":-73.302439,"median":8.168329,"eighty":137.998343,"marketCap":444993355},{"date":"2024-07-05","current":-3.47825,"twenty":-72.208373,"median":8.168329,"eighty":137.998343,"marketCap":489574115},{"date":"2024-07-12","current":-3.613766,"twenty":-71.674682,"median":8.168329,"eighty":137.998343,"marketCap":508648432},{"date":"2024-07-15","current":-3.758317,"twenty":-71.647997,"median":8.168329,"eighty":137.998343,"marketCap":528994369},{"date":"2024-08-02","current":-4.729516,"twenty":-70.687354,"median":8.235305,"eighty":139.297726,"marketCap":665693635},{"date":"2024-08-09","current":-4.774689,"twenty":-70.233717,"median":8.235305,"eighty":139.297726,"marketCap":672051740},{"date":"2024-08-16","current":-4.824378,"twenty":-69.886817,"median":8.235305,"eighty":139.297726,"marketCap":679045656},{"date":"2024-08-23","current":-4.810826,"twenty":-69.379811,"median":8.235305,"eighty":139.297726,"marketCap":677138225},{"date":"2024-08-30","current":-4.695582,"twenty":-68.84612,"median":8.235305,"eighty":139.297726,"marketCap":660917318},{"date":"2024-09-06","current":-4.079174,"twenty":-68.285745,"median":8.235305,"eighty":139.297726,"marketCap":574155972},{"date":"2024-09-13","current":-4.938462,"twenty":-67.912161,"median":8.235305,"eighty":139.297726,"marketCap":711953405},{"date":"2024-09-20","current":-5.509306,"twenty":-66.964853,"median":8.235305,"eighty":139.297726,"marketCap":794249094},{"date":"2024-09-27","current":-4.942887,"twenty":-65.87829,"median":8.235305,"eighty":139.297726,"marketCap":712591356},{"date":"2024-10-04","current":-4.672953,"twenty":-64.235019,"median":8.235305,"eighty":139.297726,"marketCap":673676340},{"date":"2024-10-11","current":-4.500373,"twenty":-63.139506,"median":8.235305,"eighty":139.297726,"marketCap":648796248},{"date":"2024-10-18","current":-4.491523,"twenty":-61.770113,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-10-25","current":-4.518073,"twenty":-60.358586,"median":8.235305,"eighty":139.297726,"marketCap":651348052},{"date":"2024-10-31","current":-4.491523,"twenty":-59.28414,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-11-08","current":-5.416378,"twenty":-57.72514,"median":8.243207,"eighty":139.447859,"marketCap":780852121},{"date":"2024-11-15","current":-5.292495,"twenty":-55.723721,"median":8.243207,"eighty":139.447859,"marketCap":762992503},{"date":"2024-11-22","current":-5.434456,"twenty":-53.82764,"median":8.243207,"eighty":139.447859,"marketCap":783458354},{"date":"2024-11-29","current":-5.447765,"twenty":-50.035478,"median":8.243207,"eighty":139.447859,"marketCap":785377027},{"date":"2024-12-06","current":-5.452201,"twenty":-48.666086,"median":8.243207,"eighty":139.447859,"marketCap":786016585},{"date":"2024-12-13","current":-5.178482,"twenty":-47.296694,"median":8.243207,"eighty":139.447859,"marketCap":787388247},{"date":"2024-12-20","current":-5.186896,"twenty":-46.111834,"median":8.243207,"eighty":139.447859,"marketCap":788667513},{"date":"2024-12-27","current":-5.165862,"twenty":-45.841544,"median":8.243207,"eighty":139.447859,"marketCap":785469348},{"date":"2025-01-03","current":-5.182689,"twenty":-45.510159,"median":8.243207,"eighty":139.447859,"marketCap":788027880},{"date":"2025-01-10","current":-5.207929,"twenty":-44.898573,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-17","current":-5.207929,"twenty":-44.137114,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-24","current":-5.237377,"twenty":-43.29527,"median":8.253213,"eighty":139.458758,"marketCap":796343109},{"date":"2025-01-31","current":-5.241583,"twenty":-42.152128,"median":8.253213,"eighty":139.458758,"marketCap":796982742},{"date":"2025-02-04","current":-5.249997,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"marketCap":798262008}],"updateTime":1779717000138},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDMO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635740188","title":"BioHarvest發布2026年業績指引 D2C與CDMO雙輪驅動","url":"https://stock-news.laohu8.com/highlight/detail?id=2635740188","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635740188?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 03:06","pubTimestamp":1778785560,"startTime":"0","endTime":"0","summary":" 植物细胞培养生物技术公司BioHarvest Sciences近日公布2026年第一季度财报。数据显示,公司一季度营收达850万美元,同比增长8%,略高于市场预期。现金及存款从去年同期的340万美元大幅增至2020万美元。 公司首席执行官Zaki Rakib在财报电话会议上重申了2026年全年业绩指引。2026年5月,BioHarvest签署了价值120万美元的第二阶段合同,用于开发应用于全球香精行业的稀有产香植物。根据协议,BioHarvest将保留所开发组合物20%的所有权,并担任制造主体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-15/doc-inhxwzrv6517436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CDMO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634640618","title":"今日普洛藥業(000739)漲停分析:CDMO放量、綠色工藝落地、新品獲批驅動","url":"https://stock-news.laohu8.com/highlight/detail?id=2634640618","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634640618?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 16:06","pubTimestamp":1778486763,"startTime":"0","endTime":"0","summary":"证券之星消息,普洛药业5月11日涨停收盘,收盘价19.27元。该股于14点4分涨停,未打开涨停,截止收盘封单资金为7663.91万元,占其流通市值0.34%。5月11日的资金流向数据方面,主力资金净流入7054.01万元,占总成交额13.61%,游资资金净流出3306.17万元,占总成交额6.38%,散户资金净流出3747.84万元,占总成交额7.23%。近5日资金流向一览见下表:该股为流感,创新药,阿尔茨海默病概念热股,当日流感概念上涨1.95%,创新药概念上涨1.85%,阿尔茨海默病概念上涨1.82%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/11/20260511805322.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/11/20260511805322.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260511/32215023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4139","BK0239","BK0060","BK0188","000739","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633543917","title":"CDMO龍頭三星生物罷工:中國CDMO企業迎訂單轉移窗口期?","url":"https://stock-news.laohu8.com/highlight/detail?id=2633543917","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633543917?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 17:23","pubTimestamp":1778232180,"startTime":"0","endTime":"0","summary":"【CDMO龙头三星生物罢工:中国CDMO企业迎订单转移窗口期?】全球生物医药合同研发生产组织(CDMO)行业的“定海神针”正面临成立以来的最大运营危机。根据公开信息,2026年5月1日起,全球生物药CDMO产能排名第一的韩国三星生物爆发全面罢工,这也是该公司自2011年成立以来的首次全线停工。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605083731575828.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605083731575828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","CDMO","BK4139","EMXC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631686139","title":"康龍化成:小分子CDMO一季度訂單加速增長來自兩方面因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2631686139","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631686139?lang=zh_tw&edition=fundamental","pubTime":"2026-04-30 16:30","pubTimestamp":1777537800,"startTime":"0","endTime":"0","summary":"证券日报网4月30日讯,康龙化成在接受调研者提问时表示,小分子CDMO一季度订单加速增长来自两方面因素,分别是项目数量增加、项目进入中后期后带来的订单金额提升,其中FollowMolecule项目从早期进入后期带来的订单额放大是核心的贡献因素。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604303726489341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","BK0216","03759","300759","BK1576","CDMO","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630360531","title":"誠達藥業2025年營收4.06億元增21.99%,CDMO成第一大收入來源,扣非淨利仍虧2669.29萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630360531","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630360531?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 18:11","pubTimestamp":1777284689,"startTime":"0","endTime":"0","summary":"数据显示,公司2025年实现营业收入4.06亿元,同比增长21.99%;归母净利润为-1192.58万元,同比增加57.56%;扣非净利润为-2669.29万元,同比增加53.72%。CDMO产品收入占比升至40.60%,首次成为第一大收入来源;左旋肉碱系列产品收入占比为58.73%,退居第二。2025年第四季度单季营业收入为1.21亿元;归母净利润为-2869.91万元;扣非净利润为-3059.55万元,当季扣非净利润亏损额高于全年累计值,表明全年经营性减亏成果未能延续至年末,Q4盈利压力明显加大。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1777283201647343535","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["301201","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630325361","title":"褪去新冠商業化紅利反而更強了!藥明康德(02359)小分子CDMO單季度收入飆至69.3億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630325361","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630325361?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 17:17","pubTimestamp":1777281471,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,4月27日晚间,药明康德发布了其首季度财报,核心业务增长动能强劲。此次小分子CDMO业务单季收入逼近70亿元大关,具有非凡的里程碑意义。数据显示,截至一季度末,药明康德小分子CDMO管线总数已达3550个。此次小分子CDMO业务在“后新冠时代”创下收入新高,是药明康德从“事件驱动”增长全面转向“平台驱动”持续高增长的有力证明,也为其在全球医药产业链中的核心枢纽地位再添坚实注脚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2125910500.SGD","LU2045819591.USD","LU0348766576.USD","LU0456842615.SGD","LU0348767384.USD","BK4139","LU1979443071.USD","LU2488822045.USD","BK1583","LU2328871848.SGD","LU0052750758.USD","LU0320764599.SGD","603259","02359","LU1969619763.USD","LU2495084118.USD","LU1997244956.HKD","BK0216","CDMO","LU1808992512.USD","BK1576","LU2242644610.SGD","BK1141","LU1997245177.USD","LU1046422090.SGD","LU1934453819.USD","LU1997245094.SGD","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630635623","title":"港股異動 | 凱萊英(06821)尾盤升逾5% 20億元化學大分子CDMO項目落地天津 TIDES持續擴能擴產","url":"https://stock-news.laohu8.com/highlight/detail?id=2630635623","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630635623?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 15:41","pubTimestamp":1777275714,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,凯莱英(06821)尾盘涨超5%,截至发稿,涨5.13%,报104.5港元,成交额1.18亿港元。消息面上,凯莱英化学大分子CDMO项目落地天津经开区。该项目将进一步提升公司在多肽、寡核苷酸(TIDES)等新分子类型的CDMO一站式服务能力,更好满足全球合作伙伴的多元需求。浙商证券此前指出,考虑到凯莱英小分子CDMO不错的在手PPQ项目,我们认为小分子CDMO业务仍具有较强的成长性。新兴业务板块多肽、寡核苷酸、ADC相关CDMO、制剂CDMO等仍有较大的成长空间和业绩弹性,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","VXUS","06821","BK4585","BK4588","BK4139","BK0239","CDMO","BK1191","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629974938","title":"港股異動 | 凱萊英(06821)午後漲近6% 20億元化學大分子創新藥CDMO項目落地天津經開區","url":"https://stock-news.laohu8.com/highlight/detail?id=2629974938","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629974938?lang=zh_tw&edition=fundamental","pubTime":"2026-04-24 14:26","pubTimestamp":1777011981,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,凯莱英午后涨近6%,截至发稿,涨5.49%,报97.1港元,成交额4458.26万港元。公开数据显示,2025年凯莱英化学大分子CDMO板块实现营业收入10.28亿元,同比增长123.72%,成为公司增长最为迅速的业务单元。公司预计26年多肽PPQ项目将达4个且多肽固相合成产能将从25年底的4.5万升增至26年底的6.9万升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4588","CDMO","VXUS","06821","BK0239","002821","BK4585","BK0132","159992","BK1574","BK4139","06978","LU1328615791.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624526715","title":"【機構調研精選】這家CRO公司年初至今新簽訂單保持增長勢頭,小分子CDMO服務毛利率有望提高!","url":"https://stock-news.laohu8.com/highlight/detail?id=2624526715","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624526715?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 09:40","pubTimestamp":1775094000,"startTime":"0","endTime":"0","summary":"人民财讯4月2日电,康龙化成(300759)3月31日召开电话会议,摩根士丹利、高盛证券、花旗证券、人保养老、新华资产、泰康资产、博时基金等180余家机构参会。康龙化成在电话会议中表示,2025年,公司新签订单金额同比增长超过14%。过去的一年,公司CDMO业务,在商业化生产方面取得了积极的进展。公司位于宁波和绍兴的原料药生产车间,历史性地通过了FDA批准前现场检查。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604023693041060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CDMO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624299599","title":"康龍化成:製劑商業化車間投產獲國際大藥企訂單 小分子CDMO毛利率有望提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2624299599","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624299599?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 17:16","pubTimestamp":1775034962,"startTime":"0","endTime":"0","summary":"每经AI快讯,4月1日,康龙化成(300759.SZ)发布投资者关系活动记录表公告,公司位于北京第二园区的制剂商业化生产车间建设完成,并于2026年第一季度与一家国际大型制药公司签订战略合作协议,为其首个注册申报的口服小分子GLP-1受体激动剂提供商业化生产服务。报告期内,公司新签订单金额同比增长超过14%,新增客户超过950家,活跃客户超过3,300家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604013691983183.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604013691983183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300759","CDMO","BK1576","BK1141","BK4139","03759","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620425493","title":"東曜藥業-B(01875)發布年度業績,收益7.48億元 戰略轉型CDMO成果顯著","url":"https://stock-news.laohu8.com/highlight/detail?id=2620425493","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620425493?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 22:03","pubTimestamp":1773842603,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东曜药业-B 发布截至2025年12月31日止年度业绩,该集团取得收益人民币7.48亿元,同比减少31.93%;研发开支8567.5万元,同比增加8.02%;公司权益持有人应占亏损约1亿元,每股亏损0.14元。公告称,产品销售收入为4.88亿元,同比下降44%,此变化主要系市场竞争加剧。CDMO业务收入为2.35亿元,同比增长13%。全年新增项目60个,项目总数累计至213个,其中ADC相关项目占比达68%。已签约未完成订单达3.08亿元,同比增长61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01875","CDMO","BK1161","BK1574","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619157052","title":"美國OTC市場Scorpius Holdings, Inc.盤中異動 早盤股價大漲25.00%報0.015美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619157052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619157052?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 22:03","pubTimestamp":1773324181,"startTime":"0","endTime":"0","summary":"北京时间2026年03月12日22时03分,美国OTC市场Scorpius Holdings, Inc.股票出现波动,股价快速上涨25.00%。截至发稿,该股报0.015美元/股,成交量382股,换手率0.00%,振幅24.17%。美国OTC市场Scorpius Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.75%。美国OTC市场Scorpius Holdings, Inc.公司简介:Scorpius Holdings Inc 是一家综合合同开发和制造组织 ,专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312220301a4643d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312220301a4643d9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SCPX","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618259096","title":"新華製藥:公司構建創新藥+特色原料藥+高端製劑+CDMO立體佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2618259096","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618259096?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 20:10","pubTimestamp":1773058240,"startTime":"0","endTime":"0","summary":"证券日报网讯3月9日,新华制药在互动平台回答投资者提问时表示,公司以大研发+全产业链+国际化为核心,构建创新药+特色原料药+高端制剂+CDMO的立体布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603093666266727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","BK1161","06978","BK1574","000756","159992","BK4139","BK0239","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613748599","title":"美國OTC市場Scorpius Holdings, Inc.盤中異動 下午盤快速上漲72.41%報0.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613748599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613748599?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 03:17","pubTimestamp":1771874221,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日03时17分,美国OTC市场Scorpius Holdings, Inc.股票出现波动,股价快速上涨72.41%。截至发稿,该股报0.010美元/股,成交量833股,换手率0.00%,振幅72.41%。美国OTC市场Scorpius Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.43%。美国OTC市场Scorpius Holdings, Inc.公司简介:Scorpius Holdings Inc 是一家综合合同开发和制造组织 ,专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224031701a716badc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224031701a716badc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","SCPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610021215","title":"大行評級丨高盛:內地醫療健康板塊的強勁趨勢將延續,對CDMO企業看好轉趨建設性","url":"https://stock-news.laohu8.com/highlight/detail?id=2610021215","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610021215?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 10:47","pubTimestamp":1770605223,"startTime":"0","endTime":"0","summary":"高盛发表研报指,去年内地医疗健康板块的强劲趋势将延续至今年,但投资者考虑估值时纳入更多研发管线的价值,因此,股份交易时更多基于企业的实际执行能力,而非单纯的授权交易预期。今年要获得超越行业的回报,更依赖于关键数据公布、实际成交,以及盈利兑现或转折点的能见度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260209/32006893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159760","XLV","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609294763","title":"普洛藥業:CDMO項目數持續保持較快增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2609294763","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609294763?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 15:34","pubTimestamp":1770276843,"startTime":"0","endTime":"0","summary":"证券之星消息,普洛药业02月05日在投资者关系平台上答复投资者关心的问题。近年来,公司CDMO项目数持续保持较快增长,且逐渐进入商业化生产阶段,有助于CDMO产能利用率的回升;但公司CDMO项目与产能涉及多个子公司、众多生产线,部分产线的生产旺盛并不完全代表公司整体业务情况,也不构成对公司经营业绩的预期指引。请广大投资者以公司披露的公告为准,谨慎分析判断,注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260205/32000606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0060","BK0188","000739","BK0239","BK4139","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607049601","title":"外資CDMO紛紛易手,它們在華消失殆盡了 | 海斌訪談","url":"https://stock-news.laohu8.com/highlight/detail?id=2607049601","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607049601?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 21:58","pubTimestamp":1769781533,"startTime":"0","endTime":"0","summary":"“不光是在收缩,是在消失。”澳斯康创始人罗顺近期接受第一财经记者采访时,这样评价跨国CDMO在华业务。CDMO是指合同研发和生产组织,它是制药产业链分工日益专业化的结果。2020年左右,一大批知名跨国企业如龙沙、赛默飞世尔、默克等都在中国投资了CDMO业务,并对中国业务寄予厚望。现在,潮水已经退去。目前,还在中国开展CDMO业务的跨国企业几乎只有德国的勃林格殷格翰了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601303637350971.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601303637350971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CDMO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607773294","title":"千億藥明系,連環資本局","url":"https://stock-news.laohu8.com/highlight/detail?id=2607773294","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607773294?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 10:25","pubTimestamp":1769653543,"startTime":"0","endTime":"0","summary":"收购与出售药明系的资本动作,一轮接一轮。药明系资本运作1.02015年,上市美股8年的药明康德提出私有化方案。之后,药明康德多次澄清,李革团队也推出回购计划。药明系资本运作2.0根据业绩预告,2025年药明康德实现营收、经调整归母净利润、扣非净利润分别为454.56亿元、149.57亿元、132.4亿元,同比增长15.84%、41.33%、32.56%。另一方面,药明康德的研发投入收缩,2025年前三季度同比下降13.7%,研发费用率2.5%,较2024年同期的3.4%有明显下滑。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1769221590141206927","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0327786744.USD","LU1934453819.USD","LU1688375341.USD","LU2328871848.SGD","LU0359201612.USD","BK1141","BK1576","BK1589","LU1720050803.USD","BK4080","SG9999002463.SGD","BK4139","LU3063872942.SGD","LU0516422952.EUR","LU1997244956.HKD","LU0051755006.USD","LU0359202008.SGD","LU0326950275.SGD","SG9999002562.SGD","LU0348735423.USD","LU0708995583.HKD","LU0140636845.USD","LU0456827905.SGD","BK1521","BK0216","LU0979878070.USD","603259","BK4231","LU0823426480.USD","02268","IE00B0JY6N72.USD","02269","LU0516422366.SGD","LU1242518931.SGD","CDMO","LU0819121731.USD","LU1997245177.USD","ADC","LU0039217434.USD","LU2488822045.USD","SG9999014674.SGD","LU1997245094.SGD","BK1610","LU0417516738.SGD","LU0856984785.SGD","LU0052750758.USD","LU0456846285.SGD","LU0307460666.USD","LU0456842615.SGD","LU0516423091.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603991833","title":"515億温州富豪,28億吞併蘇州藥企","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991833","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603991833?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 21:42","pubTimestamp":1768570978,"startTime":"0","endTime":"0","summary":"温州医药首富李革,拿下一家同行。1月14日晚,他实控的药明合联,宣布将以现金要约方式,以31亿港元的估值,约合28亿人民币,控股东曜药业。李革的药明系较为慷慨,出价4港元/股,相较12月下旬2港元左右的股价,刚好溢价一倍,考虑部分购股权注销价为1.7665港元,其要约最高代价约27.9亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601163622167671.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601163622167671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0823426480.USD","LU1688375341.USD","LU0708995583.HKD","LU1794554557.SGD","CDMO","LU0516422440.USD","LU0516422952.EUR","BK1589","LU0456846285.SGD","LU0856984785.SGD","LU0417516738.SGD","BK1610","LU0417516902.SGD","LU0348825331.USD","LU0823426308.USD","BK1521","LU0052750758.USD","LU0572944931.SGD","LU0140636845.USD","LU1720050803.USD","02269","LU2488822045.USD","LU0348735423.USD","LU1242518857.USD","LU0039217434.USD","SG9999002562.SGD","LU0516422366.SGD","LU0516423174.USD","LU1242518931.SGD","LU0979878070.USD","BK4139","LU0516423091.SGD","SG9999002463.SGD","LU0307460666.USD","02268","LU0051755006.USD","LU0456827905.SGD","LU2039709279.SGD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0181495838.USD","LU0326950275.SGD","LU0359201612.USD","LU0359202008.SGD","BK1576","BK1141","LU0588546209.SGD","SG9999014674.SGD","LU0043850808.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603610556","title":"業績盈喜, 控股收購東曜藥業,藥明合聯(02268)進一步穩固ADC CDMO市場地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2603610556","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603610556?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 23:32","pubTimestamp":1768404738,"startTime":"0","endTime":"0","summary":"同时,通过此次控股收购,药明合联亦希望进一步丰富其项目组合并扩大其客户群,稳固其在 ADC CDMO 领域的领导地位。药明合联早已布局人才梯队建设,截至2025年底,团队规模已突破2600人。截至2025年12月底,药明合联在全球合作客户数量已超过630家,iCMC项目总数达到252个。这一举措不仅能实现产能的本地化交付,更能进一步深化公司在全球生物偶联药CDMO领域的市场覆盖,巩固行业领先地位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999014674.SGD","CDMO","BK4231","LU2488822045.USD","ADC","02268","BK4139","BK1141","BK4080"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}